Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2008 3
2020 110
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 32669323

114 results
Results by year
Filters applied: . Clear all
Page 1
Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19.
Wysocki J, Lores E, Ye M, Soler MJ, Batlle D. Wysocki J, et al. J Am Soc Nephrol. 2020 Sep;31(9):1941-1943. doi: 10.1681/ASN.2020050667. Epub 2020 Jul 15. J Am Soc Nephrol. 2020. PMID: 32669323 No abstract available.
ACE2 (Angiotensin-Converting Enzyme 2), COVID-19, and ACE Inhibitor and Ang II (Angiotensin II) Receptor Blocker Use During the Pandemic: The Pediatric Perspective.
South AM, Brady TM, Flynn JT. South AM, et al. Hypertension. 2020 Jul;76(1):16-22. doi: 10.1161/HYPERTENSIONAHA.120.15291. Epub 2020 May 5. Hypertension. 2020. PMID: 32367746 Review.
COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know.
Dhawan R, Gundry RL, Brett-Major DM, Mahr C, Thiele GM, Lindsey ML, Anderson DR. Dhawan R, et al. J Mol Cell Cardiol. 2020 Jul;144:12-14. doi: 10.1016/j.yjmcc.2020.04.026. Epub 2020 Apr 24. J Mol Cell Cardiol. 2020. PMID: 32339565 Free PMC article. No abstract available.
Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19.
Kai H, Kai M. Kai H, et al. Hypertens Res. 2020 Jul;43(7):648-654. doi: 10.1038/s41440-020-0455-8. Epub 2020 Apr 27. Hypertens Res. 2020. PMID: 32341442 Free PMC article. Review.
Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
Sommerstein R, Kochen MM, Messerli FH, Gräni C. Sommerstein R, et al. J Am Heart Assoc. 2020 Apr 7;9(7):e016509. doi: 10.1161/JAHA.120.016509. Epub 2020 Apr 1. J Am Heart Assoc. 2020. PMID: 32233753 Free PMC article. No abstract available.
The role of ACEIs/ARBs in COVID-19: Friend or foe?
Zhou Z, Qiu Y, Tao J. Zhou Z, et al. Med Hypotheses. 2020 Sep;142:109810. doi: 10.1016/j.mehy.2020.109810. Epub 2020 May 5. Med Hypotheses. 2020. PMID: 32413701 Free PMC article. No abstract available.
Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.
Danser AHJ, Epstein M, Batlle D. Danser AHJ, et al. Hypertension. 2020 Jun;75(6):1382-1385. doi: 10.1161/HYPERTENSIONAHA.120.15082. Epub 2020 Mar 25. Hypertension. 2020. PMID: 32208987 Free PMC article.
Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury.
Sarzani R, Giulietti F, Di Pentima C, Giordano P, Spannella F. Sarzani R, et al. Am J Physiol Lung Cell Mol Physiol. 2020 Aug 1;319(2):L325-L336. doi: 10.1152/ajplung.00189.2020. Epub 2020 Jul 8. Am J Physiol Lung Cell Mol Physiol. 2020. PMID: 32639866 Free PMC article. Review.
Focus on clinical practice: angiotensin-converting enzyme 2 and corona virus disease 2019: pathophysiology and clinical implications.
Barillà F, Bassareo PP, Calcaterra G, Romeo F, Mehta JL. Barillà F, et al. J Cardiovasc Med (Hagerstown). 2020 Sep;21(9):630-633. doi: 10.2459/JCM.0000000000001071. J Cardiovasc Med (Hagerstown). 2020. PMID: 32740495 Review.
Risks of ACE Inhibitor and ARB Usage in COVID-19: Evaluating the Evidence.
Sriram K, Insel PA. Sriram K, et al. Clin Pharmacol Ther. 2020 Aug;108(2):236-241. doi: 10.1002/cpt.1863. Epub 2020 May 10. Clin Pharmacol Ther. 2020. PMID: 32320478 Free PMC article. Review.
114 results
Jump to page